GUGGENHIME ANDREW
Insider CIK 1230724 · DERM COO and CFO · CRBU Director · MTCR Director · PCVX President and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 7,155 | $60.36 | $431.9K | 95,316 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 7,155 | $60.36 | $431.9K | 95,316 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 1,432 | $61.58 | $88.2K | 102,471 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 1,432 | $61.58 | $88.2K | 102,471 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,273 | $60.74 | $77.3K | 103,903 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,273 | $60.74 | $77.3K | 103,903 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 10,000 | — | $0 | 216,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 3,044 | $54.18 | $164.9K | 105,176 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 10,000 | $5.35 | $53.5K | 115,176 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 6,956 | $53.76 | $374.0K | 108,220 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-08-03 | 2026-08-05 | 10,000 | — | $0 | 216,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 3,044 | $54.18 | $164.9K | 105,176 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-08-03 | 2026-08-05 | 6,956 | $53.76 | $374.0K | 108,220 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-08-03 | 2026-08-05 | 10,000 | $5.35 | $53.5K | 115,176 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-07-06 | 2026-07-06 | 10,000 | — | $0 | 226,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-06 | 2026-07-06 | 7,913 | $57.16 | $452.3K | 106,482 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-07-06 | 2026-07-06 | 2,087 | $57.76 | $120.5K | 104,395 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-07-06 | 2026-07-06 | 10,000 | $5.35 | $53.5K | 114,395 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-06-18 | 2026-06-18 | 10,000 | — | $0 | 236,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-06-18 | 2026-06-18 | 10,000 | $5.35 | $53.5K | 114,395 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-06-18 | 2026-06-18 | 10,000 | $53.00 | $530.0K | 104,395 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-09 | 2026-03-11 | 1,021 | $59.32 | $60.6K | 104,395 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-02 | 2026-03-02 | 1,009 | $61.98 | $62.5K | 105,416 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-02-28 | 2026-03-02 | 898 | $61.98 | $55.7K | 106,425 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 74,993 | — | $0 | 74,993 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-02-26 | 2026-03-02 | 44,864 | — | $0 | 107,323 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2026-01-14 | 2026-01-16 | 61,850 | — | $0 | 62,459 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2026-01-14 | 2026-01-16 | 61,850 | — | $0 | 61,850 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-08 | 2025-09-10 | 2,890 | $32.41 | $93.7K | 124,309 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,270 | $31.56 | $40.1K | 131,009 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 2,381 | $31.56 | $75.1K | 128,628 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 1,429 | $31.56 | $45.1K | 127,199 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-04-07 | 2025-04-09 | 4,777 | — | $0 | 121,115 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-04-07 | 2025-04-09 | 4,777 | $20.93 | $100.0K | 131,950 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-03-03 | 2025-03-03 | 3,809 | $72.10 | $274.6K | 127,173 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 1,270 | $73.02 | $92.7K | 130,982 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 75,991 | — | $0 | 75,991 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-02-27 | 2025-03-03 | 22,761 | — | $0 | 132,252 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-02-18 | 2025-02-19 | 8,000 | — | $0 | 246,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-18 | 2025-02-19 | 1,818 | $84.58 | $153.8K | 109,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-18 | 2025-02-19 | 6,182 | $83.64 | $517.1K | 111,309 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-02-18 | 2025-02-19 | 8,000 | $5.35 | $42.8K | 117,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-01-21 | 2025-01-22 | 8,000 | — | $0 | 254,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-21 | 2025-01-22 | 683 | $87.70 | $59.9K | 109,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-21 | 2025-01-22 | 1,999 | $87.25 | $174.4K | 110,174 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-21 | 2025-01-22 | 5,318 | $86.08 | $457.8K | 112,173 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-01-21 | 2025-01-22 | 8,000 | $5.35 | $42.8K | 117,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-12-18 | 2024-12-19 | 8,000 | — | $0 | 262,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 3,157 | $89.31 | $282.0K | 109,771 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-12-18 | 2024-12-19 | 8,000 | $5.35 | $42.8K | 117,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 280 | $90.24 | $25.3K | 109,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 3,373 | $88.70 | $299.2K | 112,928 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-18 | 2024-12-19 | 1,190 | $87.26 | $103.8K | 116,301 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-18 | 2024-11-19 | 8,000 | — | $0 | 270,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-18 | 2024-11-19 | 132 | $87.05 | $11.5K | 109,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-18 | 2024-11-19 | 1,757 | $86.49 | $152.0K | 109,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-18 | 2024-11-19 | 6,111 | $85.60 | $523.1K | 111,380 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-18 | 2024-11-19 | 8,000 | $5.35 | $42.8K | 117,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 35,661 | — | $0 | 35,661 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 87,481 | — | $0 | 87,481 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-25 | 2024-10-28 | 19,108 | — | $0 | 125,892 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-25 | 2024-10-28 | 19,108 | $20.93 | $399.9K | 109,491 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 14,000 | — | $0 | 278,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 12,000 | — | $0 | 292,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 8,000 | — | $0 | 304,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 8,000 | — | $0 | 312,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 36,114 | $115.26 | $4.16M | 96,269 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 14,000 | $5.35 | $74.9K | 132,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 5,886 | $116.19 | $683.9K | 90,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 8,000 | $5.35 | $42.8K | 106,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 8,000 | $5.35 | $42.8K | 98,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 12,000 | $5.35 | $64.2K | 118,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-18 | 2024-09-19 | 8,000 | — | $0 | 320,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 829 | $117.53 | $97.4K | 90,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-18 | 2024-09-19 | 8,000 | $5.35 | $42.8K | 98,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 5,485 | $115.60 | $634.1K | 92,898 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 1,686 | $116.29 | $196.1K | 91,212 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-09-03 | 2024-09-05 | 6,337 | $110.15 | $698.0K | 90,383 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-08-19 | 2024-08-20 | 8,000 | — | $0 | 328,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 4,994 | $78.25 | $390.8K | 99,726 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 3,006 | $79.14 | $237.9K | 96,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-08-19 | 2024-08-20 | 8,000 | $5.35 | $42.8K | 104,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-07-18 | 2024-07-22 | 8,000 | — | $0 | 336,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-18 | 2024-07-22 | 2,500 | $81.06 | $202.7K | 99,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-07-18 | 2024-07-22 | 8,000 | $5.35 | $42.8K | 104,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-18 | 2024-07-22 | 1,479 | $82.32 | $121.8K | 97,646 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-18 | 2024-07-22 | 926 | $83.14 | $77.0K | 96,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-18 | 2024-07-22 | 3,095 | $80.12 | $248.0K | 101,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-06-18 | 2024-06-20 | 8,000 | — | $0 | 344,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-06-18 | 2024-06-20 | 8,000 | $5.35 | $42.8K | 104,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-18 | 2024-06-20 | 348 | $72.56 | $25.3K | 96,720 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-18 | 2024-06-20 | 7,652 | $71.89 | $550.1K | 97,068 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-05-20 | 2024-05-22 | 8,000 | — | $0 | 352,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 3,544 | $74.40 | $263.7K | 100,135 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-20 | 2024-05-22 | 4,456 | $75.46 | $336.2K | 95,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-05-20 | 2024-05-22 | 8,000 | $5.35 | $42.8K | 103,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-04-18 | 2024-04-22 | 8,000 | — | $0 | 360,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-04-18 | 2024-04-22 | 8,000 | $5.35 | $42.8K | 103,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-18 | 2024-04-22 | 376 | $61.90 | $23.3K | 95,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-18 | 2024-04-22 | 7,624 | $61.24 | $466.9K | 96,055 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-03-18 | 2024-03-20 | 8,000 | — | $0 | 368,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-03-18 | 2024-03-20 | 8,000 | $5.35 | $42.8K | 103,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-18 | 2024-03-20 | 236 | $69.64 | $16.4K | 95,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-18 | 2024-03-20 | 7,764 | $69.00 | $535.7K | 95,915 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-02 | 2024-03-04 | 3,795 | $71.55 | $271.5K | 95,679 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-02-29 | 2024-03-04 | 20,000 | — | $0 | 99,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-20 | 2024-02-22 | 8,000 | — | $0 | 376,827 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-20 | 2024-02-22 | 8,000 | $5.35 | $42.8K | 87,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-20 | 2024-02-22 | 2,751 | $75.17 | $206.8K | 79,814 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-20 | 2024-02-22 | 340 | $75.80 | $25.8K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-20 | 2024-02-22 | 4,909 | $74.08 | $363.7K | 82,565 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-18 | 2024-01-19 | 8,000 | — | $0 | 384,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-18 | 2024-01-19 | 3,127 | $61.19 | $191.3K | 79,960 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-18 | 2024-01-19 | 23 | $63.35 | $1.5K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-18 | 2024-01-19 | 8,000 | $5.35 | $42.8K | 87,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-18 | 2024-01-19 | 463 | $61.88 | $28.7K | 79,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-18 | 2024-01-19 | 4,387 | $60.28 | $264.4K | 83,087 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-18 | 2023-12-20 | 8,000 | — | $0 | 392,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 7,883 | $60.17 | $474.3K | 79,591 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-18 | 2023-12-20 | 8,000 | $5.35 | $42.8K | 87,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 117 | $60.79 | $7.1K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-14 | 2023-12-18 | 14,000 | — | $0 | 400,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 14,000 | $60.22 | $843.1K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-14 | 2023-12-18 | 14,000 | $5.35 | $74.9K | 93,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-11-20 | 2023-11-22 | 8,000 | — | $0 | 414,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-20 | 2023-11-22 | 7,876 | $51.12 | $402.6K | 79,598 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-11-20 | 2023-11-22 | 8,000 | $5.35 | $42.8K | 87,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-11-20 | 2023-11-22 | 124 | $51.95 | $6.4K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-10-18 | 2023-10-20 | 8,000 | — | $0 | 422,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-10-18 | 2023-10-20 | 8,000 | $5.35 | $42.8K | 87,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-18 | 2023-10-20 | 503 | $46.32 | $23.3K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-18 | 2023-10-20 | 7,497 | $45.89 | $344.0K | 79,977 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 3,568 | $51.00 | $182.0K | 79,474 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-03-02 | 2023-03-03 | 1,727 | $41.49 | $71.7K | 82,002 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-03-01 | 2023-03-03 | 22,500 | — | $0 | 83,729 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 42,000 | — | $0 | 42,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-12-30 | 2023-01-04 | 23,691 | — | $0 | 430,827 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-12-30 | 2023-01-04 | 23,691 | $5.35 | $126.7K | 61,229 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-09-19 | 2022-09-21 | 3,100 | — | $0 | 454,518 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-19 | 2022-09-21 | 477 | $26.52 | $12.7K | 37,538 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-09-19 | 2022-09-21 | 3,100 | $5.35 | $16.6K | 40,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-09-19 | 2022-09-21 | 2,623 | $26.02 | $68.3K | 38,015 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2022-09-02 | 2022-09-07 | 4,649 | $26.38 | $122.6K | 37,538 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-08-29 | 2022-08-29 | 17,653 | — | $0 | 457,618 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-08-29 | 2022-08-29 | 17,653 | $5.35 | $94.4K | 59,840 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-29 | 2022-08-29 | 17,653 | $28.00 | $494.3K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-08-26 | 2022-08-29 | 1,295 | — | $0 | 475,271 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-26 | 2022-08-29 | 1,295 | $28.00 | $36.3K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-08-26 | 2022-08-29 | 1,295 | $5.35 | $6.9K | 43,482 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 17,052 | — | $0 | 476,566 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-25 | 2022-08-29 | 17,052 | $28.00 | $477.5K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 17,052 | $5.35 | $91.2K | 59,239 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-08-18 | 2022-08-22 | 3,100 | — | $0 | 493,618 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-18 | 2022-08-22 | 549 | $25.89 | $14.2K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-08-18 | 2022-08-22 | 2,551 | $25.13 | $64.1K | 42,736 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-08-18 | 2022-08-22 | 3,100 | $5.35 | $16.6K | 45,287 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-07-18 | 2022-07-20 | 3,100 | — | $0 | 496,718 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-07-18 | 2022-07-20 | 3,100 | $5.35 | $16.6K | 45,287 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-18 | 2022-07-20 | 3,091 | $24.53 | $75.8K | 42,196 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-18 | 2022-07-20 | 9 | $25.00 | $225 | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-07-08 | 2022-07-12 | 3,100 | — | $0 | 499,818 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-07-08 | 2022-07-12 | 3,100 | $24.00 | $74.4K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-07-08 | 2022-07-12 | 3,100 | $5.35 | $16.6K | 45,287 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2022-05-18 | 2022-09-06 | 16,500 | — | $0 | 16,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-05-18 | 2022-05-20 | 3,100 | — | $0 | 502,918 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-05-18 | 2022-05-20 | 3,100 | $5.35 | $16.6K | 45,287 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-05-18 | 2022-05-20 | 2,520 | $24.26 | $61.1K | 42,767 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-05-18 | 2022-05-20 | 580 | $25.22 | $14.6K | 42,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-04-18 | 2022-04-20 | 3,100 | — | $0 | 506,018 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-04-18 | 2022-04-20 | 3,100 | $24.05 | $74.6K | 40,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-04-18 | 2022-04-20 | 3,100 | $5.35 | $16.6K | 43,725 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-03-18 | 2022-03-22 | 3,100 | — | $0 | 509,118 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-03-18 | 2022-03-22 | 3,100 | $5.35 | $16.6K | 43,725 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-03-18 | 2022-03-22 | 3,100 | $26.13 | $81.0K | 40,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-03-02 | 2022-03-04 | 225,000 | — | $0 | 225,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-03-02 | 2022-03-04 | 37,500 | — | $0 | 40,625 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 6,200 | — | $0 | 512,218 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2022-03-01 | 2022-03-03 | 6,200 | $24.00 | $148.8K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 6,200 | $5.35 | $33.2K | 9,325 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-12-23 | 2021-12-28 | 3,100 | — | $0 | 518,418 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-12-23 | 2021-12-28 | 3,100 | $24.00 | $74.4K | 3,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-12-23 | 2021-12-28 | 3,100 | $5.35 | $16.6K | 6,225 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2021-12-20 | 2021-12-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2021-11-18 | 2021-11-22 | 3,100 | — | $0 | 521,518 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2021-11-18 | 2021-11-22 | 3,100 | $5.35 | $16.6K | 6,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-11-18 | 2021-11-22 | 2,985 | $24.50 | $73.1K | 3,240 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-11-18 | 2021-11-22 | 115 | $25.20 | $2.9K | 3,125 | SEC↗ |
| MTCR Metacrine, Inc. | A Award deriv | 2021-05-24 | 2021-05-25 | 16,500 | — | $0 | 16,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-04-01 | 2021-04-06 | 145,000 | — | $0 | 145,000 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 73,287 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 121 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 67,240 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 71,250 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 71,250 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 57,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 65,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 3,562 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 5,700 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 25,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 15,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 41,951 | $18.75 | $786.6K | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 3,562 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 3,563 | — | $0 | 3,562 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-19 | 2,850 | — | $0 | 5,700 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 986 | $7.91 | $7.8K | 43,392 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 2,850 | — | $0 | 37,253 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 3,563 | — | $0 | 40,816 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-08-15 | 2019-08-19 | 3,562 | — | $0 | 44,378 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 1,233 | $7.91 | $9.8K | 42,159 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-08-15 | 2019-08-19 | 1,232 | $7.91 | $9.7K | 40,927 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2019-05-17 | 2019-05-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2019-05-17 | 2019-05-21 | 25,000 | — | $0 | 43,048 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2019-05-17 | 2019-05-21 | 8,645 | $10.50 | $90.8K | 34,403 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-02-12 | 2019-02-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 3,562 | — | $0 | 7,125 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 3,563 | — | $0 | 3,562 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2018-08-15 | 2018-08-17 | 950 | — | $0 | 8,550 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-08-15 | 2018-08-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 1,232 | $9.58 | $11.8K | 17,729 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 329 | $9.58 | $3.2K | 18,961 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 3,563 | — | $0 | 19,290 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 3,562 | — | $0 | 15,727 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2018-08-15 | 2018-08-17 | 950 | — | $0 | 12,165 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2018-08-15 | 2018-08-17 | 1,233 | $9.58 | $11.8K | 16,496 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 57,000 | $28.25 | $1.61M | 57,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 9,500 | — | $0 | 9,500 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-08-15 | 2017-08-17 | 1,188 | — | $0 | 10,687 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2017-08-15 | 2017-08-17 | 3,562 | — | $0 | 7,125 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-08-15 | 2017-08-17 | 3,562 | — | $0 | 10,671 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2017-08-15 | 2017-08-17 | 1,188 | — | $0 | 11,859 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2017-08-15 | 2017-08-17 | 1,339 | $23.58 | $31.6K | 10,520 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2017-08-15 | 2017-08-17 | 447 | $23.58 | $10.5K | 10,073 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-02-17 | 2017-02-22 | 71,250 | $33.84 | $2.41M | 71,250 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2017-02-17 | 2017-02-22 | 11,875 | — | $0 | 11,875 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-11-09 | 2016-11-10 | 4,100 | — | $0 | 120,513 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-11-09 | 2016-11-10 | 4,100 | $35.02 | $143.6K | 5,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-11-09 | 2016-11-10 | 4,100 | $5.51 | $22.6K | 9,216 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-10-11 | 2016-10-13 | 10,900 | — | $0 | 124,613 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-10-11 | 2016-10-13 | 9,295 | $34.20 | $317.9K | 6,721 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-10-11 | 2016-10-13 | 10,900 | $5.51 | $60.1K | 16,016 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-10-11 | 2016-10-13 | 1,605 | $35.13 | $56.4K | 5,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-09-19 | 2016-09-20 | 15,000 | — | $0 | 135,513 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-09-19 | 2016-09-20 | 15,000 | $35.01 | $525.1K | 5,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-09-19 | 2016-09-20 | 15,000 | $5.51 | $82.7K | 20,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-09-12 | 2016-09-14 | 10,000 | — | $0 | 150,513 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-09-12 | 2016-09-14 | 10,000 | $5.51 | $55.1K | 15,116 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-09-12 | 2016-09-14 | 10,000 | $32.53 | $325.3K | 5,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-08-15 | 2016-08-16 | 1,188 | — | $0 | 10,687 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-08-15 | 2016-08-16 | 1,188 | — | $0 | 5,563 | SEC↗ |
| DERM Dermira, Inc. | F Tax w/h | 2016-08-15 | 2016-08-16 | 447 | $31.59 | $14.1K | 5,116 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-08-11 | 2016-08-12 | 10,000 | — | $0 | 160,513 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-08-11 | 2016-08-12 | 10,000 | $31.02 | $310.2K | 4,375 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-08-11 | 2016-08-12 | 10,000 | $5.51 | $55.1K | 14,375 | SEC↗ |
| DERM Dermira, Inc. | M Exercise deriv | 2016-07-11 | 2016-07-12 | 10,000 | — | $0 | 170,513 | SEC↗ |
| DERM Dermira, Inc. | M Exercise | 2016-07-11 | 2016-07-12 | 10,000 | $5.51 | $55.1K | 14,375 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-07-11 | 2016-07-12 | 7,361 | $30.28 | $222.9K | 7,014 | SEC↗ |
| DERM Dermira, Inc. | S Sale | 2016-07-11 | 2016-07-12 | 2,639 | $29.80 | $78.6K | 4,375 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-02-05 | 2016-02-09 | 11,875 | — | $0 | 11,875 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2016-02-05 | 2016-02-09 | 71,250 | — | $0 | 71,250 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2014-10-02 | 2014-10-02 | 67,240 | — | $0 | 67,240 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2014-10-02 | 2014-10-02 | 73,287 | — | $0 | 73,287 | SEC↗ |